nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—Aminosalicylic Acids—Balsalazide—Crohn's disease	0.212	0.569	CiPCiCtD
Mesalazine—ulcerative colitis—Crohn's disease	0.17	1	CtDrD
Mesalazine—Aminosalicylic Acids—Sulfasalazine—Crohn's disease	0.161	0.431	CiPCiCtD
Mesalazine—MPO—Crohn's disease	0.075	0.727	CbGaD
Mesalazine—Olsalazine—Balsalazide—Crohn's disease	0.0716	0.569	CrCrCtD
Mesalazine—Olsalazine—Sulfasalazine—Crohn's disease	0.0542	0.431	CrCrCtD
Mesalazine—CHUK—Sulfasalazine—Crohn's disease	0.0374	0.211	CbGbCtD
Mesalazine—ALOX5—Balsalazide—Crohn's disease	0.0326	0.184	CbGbCtD
Mesalazine—PPARG—Balsalazide—Crohn's disease	0.0291	0.164	CbGbCtD
Mesalazine—PTGS2—Crohn's disease	0.0281	0.273	CbGaD
Mesalazine—IKBKB—Sulfasalazine—Crohn's disease	0.027	0.153	CbGbCtD
Mesalazine—ALOX5—Sulfasalazine—Crohn's disease	0.0146	0.0824	CbGbCtD
Mesalazine—PPARG—Sulfasalazine—Crohn's disease	0.013	0.0735	CbGbCtD
Mesalazine—PTGS2—Balsalazide—Crohn's disease	0.00867	0.0491	CbGbCtD
Mesalazine—PTGS1—Balsalazide—Crohn's disease	0.00732	0.0414	CbGbCtD
Mesalazine—MPO—superior mesenteric artery—Crohn's disease	0.00565	0.423	CbGeAlD
Mesalazine—PTGS2—Sulfasalazine—Crohn's disease	0.00387	0.0219	CbGbCtD
Mesalazine—PTGS1—Sulfasalazine—Crohn's disease	0.00327	0.0185	CbGbCtD
Mesalazine—Malabsorption—Mercaptopurine—Crohn's disease	0.00102	0.0821	CcSEcCtD
Mesalazine—Steatorrhoea—Azathioprine—Crohn's disease	0.000838	0.0677	CcSEcCtD
Mesalazine—Oligospermia—Mercaptopurine—Crohn's disease	0.000704	0.0568	CcSEcCtD
Mesalazine—Acute febrile neutrophilic dermatosis—Azathioprine—Crohn's disease	0.000649	0.0524	CcSEcCtD
Mesalazine—Azoospermia—Mercaptopurine—Crohn's disease	0.000548	0.0442	CcSEcCtD
Mesalazine—Hepatitis toxic—Azathioprine—Crohn's disease	0.000535	0.0432	CcSEcCtD
Mesalazine—CHUK—epithelium—Crohn's disease	0.00048	0.0359	CbGeAlD
Mesalazine—CHUK—skin of body—Crohn's disease	0.000457	0.0342	CbGeAlD
Mesalazine—Drug fever—Mercaptopurine—Crohn's disease	0.000442	0.0357	CcSEcCtD
Mesalazine—CHUK—lymphoid tissue—Crohn's disease	0.00037	0.0277	CbGeAlD
Mesalazine—CHUK—digestive system—Crohn's disease	0.000365	0.0273	CbGeAlD
Mesalazine—IKBKB—smooth muscle tissue—Crohn's disease	0.000314	0.0235	CbGeAlD
Mesalazine—IKBKB—skin of body—Crohn's disease	0.00031	0.0232	CbGeAlD
Mesalazine—IKBKB—mammalian vulva—Crohn's disease	0.000283	0.0212	CbGeAlD
Mesalazine—Olsalazine—IFNG—Crohn's disease	0.000278	0.333	CrCbGaD
Mesalazine—ALOX5—smooth muscle tissue—Crohn's disease	0.000261	0.0195	CbGeAlD
Mesalazine—Hepatic necrosis—Mercaptopurine—Crohn's disease	0.000254	0.0205	CcSEcCtD
Mesalazine—IKBKB—lymphoid tissue—Crohn's disease	0.000251	0.0188	CbGeAlD
Mesalazine—IKBKB—digestive system—Crohn's disease	0.000248	0.0186	CbGeAlD
Mesalazine—Oral candidiasis—Mercaptopurine—Crohn's disease	0.000232	0.0188	CcSEcCtD
Mesalazine—MPO—epithelium—Crohn's disease	0.000229	0.0171	CbGeAlD
Mesalazine—Bone marrow depression—Mercaptopurine—Crohn's disease	0.000219	0.0176	CcSEcCtD
Mesalazine—MPO—skin of body—Crohn's disease	0.000218	0.0163	CbGeAlD
Mesalazine—CHUK—lymph node—Crohn's disease	0.000209	0.0156	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—Crohn's disease	0.000208	0.0156	CbGeAlD
Mesalazine—ALOX5—digestive system—Crohn's disease	0.000206	0.0154	CbGeAlD
Mesalazine—PPARG—epithelium—Crohn's disease	0.000203	0.0152	CbGeAlD
Mesalazine—PTGS2—gall bladder—Crohn's disease	0.000201	0.015	CbGeAlD
Mesalazine—PPARG—smooth muscle tissue—Crohn's disease	0.000196	0.0146	CbGeAlD
Mesalazine—Cholestasis—Mercaptopurine—Crohn's disease	0.000194	0.0157	CcSEcCtD
Mesalazine—PPARG—skin of body—Crohn's disease	0.000193	0.0145	CbGeAlD
Mesalazine—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.000191	0.0154	CcSEcCtD
Mesalazine—Interstitial pneumonia—Azathioprine—Crohn's disease	0.000182	0.0147	CcSEcCtD
Mesalazine—PTGS2—mouth—Crohn's disease	0.000178	0.0134	CbGeAlD
Mesalazine—MPO—lymphoid tissue—Crohn's disease	0.000176	0.0132	CbGeAlD
Mesalazine—PPARG—mammalian vulva—Crohn's disease	0.000176	0.0132	CbGeAlD
Mesalazine—Liver injury—Mercaptopurine—Crohn's disease	0.000175	0.0142	CcSEcCtD
Mesalazine—MPO—digestive system—Crohn's disease	0.000174	0.013	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—Crohn's disease	0.000156	0.0117	CbGeAlD
Mesalazine—PPARG—digestive system—Crohn's disease	0.000155	0.0116	CbGeAlD
Mesalazine—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.000148	0.0119	CcSEcCtD
Mesalazine—IKBKB—lymph node—Crohn's disease	0.000142	0.0106	CbGeAlD
Mesalazine—Candida infection—Mercaptopurine—Crohn's disease	0.000141	0.0114	CcSEcCtD
Mesalazine—Aminosalicylic Acid—MPO—Crohn's disease	0.000139	0.166	CrCbGaD
Mesalazine—Mouth ulceration—Mercaptopurine—Crohn's disease	0.000133	0.0108	CcSEcCtD
Mesalazine—Bone marrow depression—Azathioprine—Crohn's disease	0.00013	0.0105	CcSEcCtD
Mesalazine—Interstitial lung disease—Azathioprine—Crohn's disease	0.000124	0.01	CcSEcCtD
Mesalazine—ALOX5—lymph node—Crohn's disease	0.000118	0.0088	CbGeAlD
Mesalazine—Oesophageal ulcer—Prednisone—Crohn's disease	0.000116	0.00938	CcSEcCtD
Mesalazine—Cholestasis—Azathioprine—Crohn's disease	0.000116	0.00935	CcSEcCtD
Mesalazine—Hepatotoxicity—Azathioprine—Crohn's disease	0.000114	0.00919	CcSEcCtD
Mesalazine—PTGS1—epithelium—Crohn's disease	0.000109	0.00813	CbGeAlD
Mesalazine—PTGS1—smooth muscle tissue—Crohn's disease	0.000105	0.00783	CbGeAlD
Mesalazine—Liver injury—Azathioprine—Crohn's disease	0.000104	0.00844	CcSEcCtD
Mesalazine—PTGS2—epithelium—Crohn's disease	0.000104	0.00777	CbGeAlD
Mesalazine—PTGS1—skin of body—Crohn's disease	0.000103	0.00773	CbGeAlD
Mesalazine—Jaundice cholestatic—Azathioprine—Crohn's disease	0.0001	0.00808	CcSEcCtD
Mesalazine—PTGS2—smooth muscle tissue—Crohn's disease	0.0001	0.00749	CbGeAlD
Mesalazine—MPO—lymph node—Crohn's disease	9.95e-05	0.00745	CbGeAlD
Mesalazine—PTGS2—skin of body—Crohn's disease	9.87e-05	0.00739	CbGeAlD
Mesalazine—Breast disorder—Mercaptopurine—Crohn's disease	9.68e-05	0.00781	CcSEcCtD
Mesalazine—PTGS1—mammalian vulva—Crohn's disease	9.42e-05	0.00705	CbGeAlD
Mesalazine—Pancreatitis acute—Prednisone—Crohn's disease	9.17e-05	0.00741	CcSEcCtD
Mesalazine—Pancreatitis—Mercaptopurine—Crohn's disease	9.07e-05	0.00733	CcSEcCtD
Mesalazine—PPARG—lymph node—Crohn's disease	8.83e-05	0.00661	CbGeAlD
Mesalazine—Hepatocellular injury—Azathioprine—Crohn's disease	8.79e-05	0.0071	CcSEcCtD
Mesalazine—Pancytopenia—Mercaptopurine—Crohn's disease	8.79e-05	0.0071	CcSEcCtD
Mesalazine—Colitis—Azathioprine—Crohn's disease	8.44e-05	0.00681	CcSEcCtD
Mesalazine—PTGS1—digestive system—Crohn's disease	8.26e-05	0.00618	CbGeAlD
Mesalazine—Aplastic anaemia—Azathioprine—Crohn's disease	8.25e-05	0.00666	CcSEcCtD
Mesalazine—Salicylate-sodium—PTGS2—Crohn's disease	8.07e-05	0.0966	CrCbGaD
Mesalazine—Stomatitis—Mercaptopurine—Crohn's disease	8.04e-05	0.0065	CcSEcCtD
Mesalazine—PTGS2—lymphoid tissue—Crohn's disease	7.99e-05	0.00598	CbGeAlD
Mesalazine—PTGS2—digestive system—Crohn's disease	7.9e-05	0.00591	CbGeAlD
Mesalazine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	7.8e-05	0.0063	CcSEcCtD
Mesalazine—Dopamine—SLC22A5—Crohn's disease	7.74e-05	0.0926	CrCbGaD
Mesalazine—Hirsutism—Prednisone—Crohn's disease	7.29e-05	0.00589	CcSEcCtD
Mesalazine—Hepatic failure—Azathioprine—Crohn's disease	7.1e-05	0.00573	CcSEcCtD
Mesalazine—Immune system disorder—Mercaptopurine—Crohn's disease	6.69e-05	0.0054	CcSEcCtD
Mesalazine—Alopecia—Mercaptopurine—Crohn's disease	6.55e-05	0.00529	CcSEcCtD
Mesalazine—Anaemia—Mercaptopurine—Crohn's disease	5.96e-05	0.00481	CcSEcCtD
Mesalazine—Leukopenia—Mercaptopurine—Crohn's disease	5.77e-05	0.00466	CcSEcCtD
Mesalazine—Dermatitis atopic—Prednisone—Crohn's disease	5.72e-05	0.00462	CcSEcCtD
Mesalazine—Olsalazine—PTGS2—Crohn's disease	5.53e-05	0.0662	CrCbGaD
Mesalazine—Arthralgia—Mercaptopurine—Crohn's disease	5.49e-05	0.00443	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	5.45e-05	0.0044	CcSEcCtD
Mesalazine—Pancreatitis—Azathioprine—Crohn's disease	5.41e-05	0.00437	CcSEcCtD
Mesalazine—Abdominal discomfort—Azathioprine—Crohn's disease	5.29e-05	0.00427	CcSEcCtD
Mesalazine—Oedema—Mercaptopurine—Crohn's disease	5.26e-05	0.00425	CcSEcCtD
Mesalazine—Pancytopenia—Azathioprine—Crohn's disease	5.24e-05	0.00423	CcSEcCtD
Mesalazine—Diflunisal—PTGS2—Crohn's disease	5.2e-05	0.0623	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—Crohn's disease	5.2e-05	0.0623	CrCbGaD
Mesalazine—Thrombocytopenia—Mercaptopurine—Crohn's disease	5.15e-05	0.00416	CcSEcCtD
Mesalazine—Skin disorder—Mercaptopurine—Crohn's disease	5.11e-05	0.00413	CcSEcCtD
Mesalazine—Acne—Prednisone—Crohn's disease	5.03e-05	0.00407	CcSEcCtD
Mesalazine—Anorexia—Mercaptopurine—Crohn's disease	5.02e-05	0.00405	CcSEcCtD
Mesalazine—Pneumonia—Azathioprine—Crohn's disease	4.95e-05	0.00399	CcSEcCtD
Mesalazine—Delirium—Prednisone—Crohn's disease	4.92e-05	0.00398	CcSEcCtD
Mesalazine—Infestation—Azathioprine—Crohn's disease	4.92e-05	0.00397	CcSEcCtD
Mesalazine—Infestation NOS—Azathioprine—Crohn's disease	4.92e-05	0.00397	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	4.87e-05	0.00394	CcSEcCtD
Mesalazine—Amenorrhoea—Prednisone—Crohn's disease	4.82e-05	0.00389	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	4.79e-05	0.00387	CcSEcCtD
Mesalazine—PTGS1—lymph node—Crohn's disease	4.72e-05	0.00353	CbGeAlD
Mesalazine—Arthropathy—Prednisone—Crohn's disease	4.66e-05	0.00376	CcSEcCtD
Mesalazine—Hepatobiliary disease—Azathioprine—Crohn's disease	4.65e-05	0.00376	CcSEcCtD
Mesalazine—Diflunisal—ALB—Crohn's disease	4.63e-05	0.0555	CrCbGaD
Mesalazine—Agranulocytosis—Azathioprine—Crohn's disease	4.59e-05	0.00371	CcSEcCtD
Mesalazine—Decreased appetite—Mercaptopurine—Crohn's disease	4.57e-05	0.00369	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	4.54e-05	0.00367	CcSEcCtD
Mesalazine—PTGS2—lymph node—Crohn's disease	4.51e-05	0.00338	CbGeAlD
Mesalazine—Leukocytosis—Prednisone—Crohn's disease	4.51e-05	0.00364	CcSEcCtD
Mesalazine—Haemoglobin—Azathioprine—Crohn's disease	4.44e-05	0.00358	CcSEcCtD
Mesalazine—Haemorrhage—Azathioprine—Crohn's disease	4.41e-05	0.00356	CcSEcCtD
Mesalazine—Erythema multiforme—Azathioprine—Crohn's disease	4.17e-05	0.00337	CcSEcCtD
Mesalazine—Body temperature increased—Mercaptopurine—Crohn's disease	4.16e-05	0.00336	CcSEcCtD
Mesalazine—Skin exfoliation—Prednisone—Crohn's disease	4.04e-05	0.00327	CcSEcCtD
Mesalazine—Immune system disorder—Azathioprine—Crohn's disease	3.99e-05	0.00322	CcSEcCtD
Mesalazine—Mediastinal disorder—Azathioprine—Crohn's disease	3.98e-05	0.00321	CcSEcCtD
Mesalazine—Neuropathy—Prednisone—Crohn's disease	3.98e-05	0.00321	CcSEcCtD
Mesalazine—Chills—Azathioprine—Crohn's disease	3.96e-05	0.0032	CcSEcCtD
Mesalazine—Alopecia—Azathioprine—Crohn's disease	3.9e-05	0.00315	CcSEcCtD
Mesalazine—Hypersensitivity—Mercaptopurine—Crohn's disease	3.88e-05	0.00313	CcSEcCtD
Mesalazine—Ecchymosis—Prednisone—Crohn's disease	3.83e-05	0.00309	CcSEcCtD
Mesalazine—Diarrhoea—Mercaptopurine—Crohn's disease	3.6e-05	0.00291	CcSEcCtD
Mesalazine—Ill-defined disorder—Azathioprine—Crohn's disease	3.56e-05	0.00288	CcSEcCtD
Mesalazine—Anaemia—Azathioprine—Crohn's disease	3.55e-05	0.00287	CcSEcCtD
Mesalazine—Malaise—Azathioprine—Crohn's disease	3.46e-05	0.0028	CcSEcCtD
Mesalazine—Leukopenia—Azathioprine—Crohn's disease	3.44e-05	0.00278	CcSEcCtD
Mesalazine—Vomiting—Mercaptopurine—Crohn's disease	3.35e-05	0.0027	CcSEcCtD
Mesalazine—Rash—Mercaptopurine—Crohn's disease	3.32e-05	0.00268	CcSEcCtD
Mesalazine—Dermatitis—Mercaptopurine—Crohn's disease	3.32e-05	0.00268	CcSEcCtD
Mesalazine—Increased appetite—Prednisone—Crohn's disease	3.27e-05	0.00264	CcSEcCtD
Mesalazine—Myalgia—Azathioprine—Crohn's disease	3.27e-05	0.00264	CcSEcCtD
Mesalazine—Arthralgia—Azathioprine—Crohn's disease	3.27e-05	0.00264	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	3.25e-05	0.00262	CcSEcCtD
Mesalazine—Discomfort—Azathioprine—Crohn's disease	3.23e-05	0.00261	CcSEcCtD
Mesalazine—Lethargy—Prednisone—Crohn's disease	3.14e-05	0.00253	CcSEcCtD
Mesalazine—Nausea—Mercaptopurine—Crohn's disease	3.13e-05	0.00252	CcSEcCtD
Mesalazine—Infection—Azathioprine—Crohn's disease	3.12e-05	0.00252	CcSEcCtD
Mesalazine—Osteoarthritis—Prednisone—Crohn's disease	3.07e-05	0.00248	CcSEcCtD
Mesalazine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	3.07e-05	0.00248	CcSEcCtD
Mesalazine—Thrombocytopenia—Azathioprine—Crohn's disease	3.07e-05	0.00248	CcSEcCtD
Mesalazine—Skin disorder—Azathioprine—Crohn's disease	3.05e-05	0.00246	CcSEcCtD
Mesalazine—Affect lability—Prednisone—Crohn's disease	3.03e-05	0.00244	CcSEcCtD
Mesalazine—Face oedema—Prednisone—Crohn's disease	2.97e-05	0.0024	CcSEcCtD
Mesalazine—Hypotension—Azathioprine—Crohn's disease	2.93e-05	0.00237	CcSEcCtD
Mesalazine—Mood swings—Prednisone—Crohn's disease	2.91e-05	0.00235	CcSEcCtD
Mesalazine—Salicylic acid—PTGS2—Crohn's disease	2.89e-05	0.0346	CrCbGaD
Mesalazine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	2.86e-05	0.00231	CcSEcCtD
Mesalazine—Dry skin—Prednisone—Crohn's disease	2.82e-05	0.00228	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Prednisone—Crohn's disease	2.71e-05	0.00219	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Azathioprine—Crohn's disease	2.71e-05	0.00219	CcSEcCtD
Mesalazine—Abdominal distension—Prednisone—Crohn's disease	2.68e-05	0.00216	CcSEcCtD
Mesalazine—Pancreatitis—Prednisone—Crohn's disease	2.61e-05	0.0021	CcSEcCtD
Mesalazine—Feeling abnormal—Azathioprine—Crohn's disease	2.58e-05	0.00209	CcSEcCtD
Mesalazine—Salicylic acid—ALB—Crohn's disease	2.58e-05	0.0309	CrCbGaD
Mesalazine—Gastrointestinal pain—Azathioprine—Crohn's disease	2.56e-05	0.00207	CcSEcCtD
Mesalazine—Neutropenia—Prednisone—Crohn's disease	2.49e-05	0.00201	CcSEcCtD
Mesalazine—Abdominal pain—Azathioprine—Crohn's disease	2.48e-05	0.002	CcSEcCtD
Mesalazine—Body temperature increased—Azathioprine—Crohn's disease	2.48e-05	0.002	CcSEcCtD
Mesalazine—Weight increased—Prednisone—Crohn's disease	2.42e-05	0.00195	CcSEcCtD
Mesalazine—Weight decreased—Prednisone—Crohn's disease	2.4e-05	0.00194	CcSEcCtD
Mesalazine—Depression—Prednisone—Crohn's disease	2.36e-05	0.00191	CcSEcCtD
Mesalazine—Neuropathy peripheral—Prednisone—Crohn's disease	2.32e-05	0.00188	CcSEcCtD
Mesalazine—Hypersensitivity—Azathioprine—Crohn's disease	2.31e-05	0.00187	CcSEcCtD
Mesalazine—Diarrhoea—Azathioprine—Crohn's disease	2.15e-05	0.00173	CcSEcCtD
Mesalazine—Haemoglobin—Prednisone—Crohn's disease	2.14e-05	0.00173	CcSEcCtD
Mesalazine—Haemorrhage—Prednisone—Crohn's disease	2.13e-05	0.00172	CcSEcCtD
Mesalazine—Connective tissue disorder—Prednisone—Crohn's disease	2.09e-05	0.00169	CcSEcCtD
Mesalazine—Dizziness—Azathioprine—Crohn's disease	2.07e-05	0.00167	CcSEcCtD
Mesalazine—Vomiting—Azathioprine—Crohn's disease	1.99e-05	0.00161	CcSEcCtD
Mesalazine—Eye disorder—Prednisone—Crohn's disease	1.99e-05	0.00161	CcSEcCtD
Mesalazine—Rash—Azathioprine—Crohn's disease	1.98e-05	0.0016	CcSEcCtD
Mesalazine—Dermatitis—Azathioprine—Crohn's disease	1.98e-05	0.0016	CcSEcCtD
Mesalazine—Headache—Azathioprine—Crohn's disease	1.96e-05	0.00159	CcSEcCtD
Mesalazine—Angiopathy—Prednisone—Crohn's disease	1.93e-05	0.00156	CcSEcCtD
Mesalazine—Immune system disorder—Prednisone—Crohn's disease	1.92e-05	0.00155	CcSEcCtD
Mesalazine—Alopecia—Prednisone—Crohn's disease	1.88e-05	0.00152	CcSEcCtD
Mesalazine—Mental disorder—Prednisone—Crohn's disease	1.86e-05	0.0015	CcSEcCtD
Mesalazine—Nausea—Azathioprine—Crohn's disease	1.86e-05	0.0015	CcSEcCtD
Mesalazine—Erythema—Prednisone—Crohn's disease	1.85e-05	0.0015	CcSEcCtD
Mesalazine—Vision blurred—Prednisone—Crohn's disease	1.75e-05	0.00141	CcSEcCtD
Mesalazine—Ill-defined disorder—Prednisone—Crohn's disease	1.72e-05	0.00139	CcSEcCtD
Mesalazine—Anaemia—Prednisone—Crohn's disease	1.71e-05	0.00138	CcSEcCtD
Mesalazine—Angioedema—Prednisone—Crohn's disease	1.69e-05	0.00137	CcSEcCtD
Mesalazine—Malaise—Prednisone—Crohn's disease	1.67e-05	0.00135	CcSEcCtD
Mesalazine—Vertigo—Prednisone—Crohn's disease	1.66e-05	0.00134	CcSEcCtD
Mesalazine—Syncope—Prednisone—Crohn's disease	1.66e-05	0.00134	CcSEcCtD
Mesalazine—Loss of consciousness—Prednisone—Crohn's disease	1.63e-05	0.00131	CcSEcCtD
Mesalazine—Hypertension—Prednisone—Crohn's disease	1.6e-05	0.00129	CcSEcCtD
Mesalazine—Arthralgia—Prednisone—Crohn's disease	1.58e-05	0.00127	CcSEcCtD
Mesalazine—Myalgia—Prednisone—Crohn's disease	1.58e-05	0.00127	CcSEcCtD
Mesalazine—Anxiety—Prednisone—Crohn's disease	1.57e-05	0.00127	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	1.57e-05	0.00126	CcSEcCtD
Mesalazine—Discomfort—Prednisone—Crohn's disease	1.56e-05	0.00126	CcSEcCtD
Mesalazine—Anaphylactic shock—Prednisone—Crohn's disease	1.51e-05	0.00122	CcSEcCtD
Mesalazine—Oedema—Prednisone—Crohn's disease	1.51e-05	0.00122	CcSEcCtD
Mesalazine—Infection—Prednisone—Crohn's disease	1.5e-05	0.00121	CcSEcCtD
Mesalazine—Shock—Prednisone—Crohn's disease	1.49e-05	0.0012	CcSEcCtD
Mesalazine—Nervous system disorder—Prednisone—Crohn's disease	1.48e-05	0.0012	CcSEcCtD
Mesalazine—Tachycardia—Prednisone—Crohn's disease	1.47e-05	0.00119	CcSEcCtD
Mesalazine—Skin disorder—Prednisone—Crohn's disease	1.47e-05	0.00119	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisone—Crohn's disease	1.46e-05	0.00118	CcSEcCtD
Mesalazine—Anorexia—Prednisone—Crohn's disease	1.44e-05	0.00116	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Prednisone—Crohn's disease	1.38e-05	0.00111	CcSEcCtD
Mesalazine—Insomnia—Prednisone—Crohn's disease	1.37e-05	0.0011	CcSEcCtD
Mesalazine—Paraesthesia—Prednisone—Crohn's disease	1.36e-05	0.0011	CcSEcCtD
Mesalazine—Dyspepsia—Prednisone—Crohn's disease	1.33e-05	0.00107	CcSEcCtD
Mesalazine—Decreased appetite—Prednisone—Crohn's disease	1.31e-05	0.00106	CcSEcCtD
Mesalazine—Fatigue—Prednisone—Crohn's disease	1.3e-05	0.00105	CcSEcCtD
Mesalazine—Constipation—Prednisone—Crohn's disease	1.29e-05	0.00104	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisone—Crohn's disease	1.25e-05	0.00101	CcSEcCtD
Mesalazine—Gastrointestinal pain—Prednisone—Crohn's disease	1.24e-05	0.000998	CcSEcCtD
Mesalazine—Urticaria—Prednisone—Crohn's disease	1.2e-05	0.00097	CcSEcCtD
Mesalazine—Body temperature increased—Prednisone—Crohn's disease	1.19e-05	0.000965	CcSEcCtD
Mesalazine—Abdominal pain—Prednisone—Crohn's disease	1.19e-05	0.000965	CcSEcCtD
Mesalazine—Hypersensitivity—Prednisone—Crohn's disease	1.11e-05	0.000899	CcSEcCtD
Mesalazine—Asthenia—Prednisone—Crohn's disease	1.08e-05	0.000876	CcSEcCtD
Mesalazine—Pruritus—Prednisone—Crohn's disease	1.07e-05	0.000863	CcSEcCtD
Mesalazine—Diarrhoea—Prednisone—Crohn's disease	1.03e-05	0.000835	CcSEcCtD
Mesalazine—Dizziness—Prednisone—Crohn's disease	9.99e-06	0.000807	CcSEcCtD
Mesalazine—Vomiting—Prednisone—Crohn's disease	9.61e-06	0.000776	CcSEcCtD
Mesalazine—Rash—Prednisone—Crohn's disease	9.53e-06	0.000769	CcSEcCtD
Mesalazine—Dermatitis—Prednisone—Crohn's disease	9.52e-06	0.000769	CcSEcCtD
Mesalazine—Headache—Prednisone—Crohn's disease	9.47e-06	0.000765	CcSEcCtD
Mesalazine—Nausea—Prednisone—Crohn's disease	8.98e-06	0.000725	CcSEcCtD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	7.15e-06	0.000285	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TAB1—Crohn's disease	7.12e-06	0.000283	CbGpPWpGaD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	7.03e-06	0.00028	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	7.03e-06	0.00028	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—RIPK2—Crohn's disease	6.99e-06	0.000279	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—NOD2—Crohn's disease	6.99e-06	0.000278	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—RASGRP1—Crohn's disease	6.99e-06	0.000278	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD79A—Crohn's disease	6.96e-06	0.000277	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL6—Crohn's disease	6.94e-06	0.000276	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—UBE2D1—Crohn's disease	6.93e-06	0.000276	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—SMAD3—Crohn's disease	6.86e-06	0.000273	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TAGAP—Crohn's disease	6.82e-06	0.000272	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	6.82e-06	0.000271	CbGpPWpGaD
Mesalazine—IKBKB—MyD88-independent cascade—IL6—Crohn's disease	6.75e-06	0.000269	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—RIPK2—Crohn's disease	6.72e-06	0.000267	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ITGA4—Crohn's disease	6.72e-06	0.000267	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PLA2G4F—Crohn's disease	6.72e-06	0.000267	CbGpPWpGaD
Mesalazine—CHUK—Activated TLR4 signalling—IL6—Crohn's disease	6.69e-06	0.000266	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—STAT3—Crohn's disease	6.69e-06	0.000266	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.63e-06	0.000264	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—TYK2—Crohn's disease	6.62e-06	0.000264	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—RASGRP1—Crohn's disease	6.6e-06	0.000263	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—SOCS1—Crohn's disease	6.59e-06	0.000262	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	6.59e-06	0.000262	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RSPO3—Crohn's disease	6.58e-06	0.000262	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—STAT3—Crohn's disease	6.54e-06	0.000261	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	6.54e-06	0.00026	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—TYK2—Crohn's disease	6.51e-06	0.000259	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TAB1—Crohn's disease	6.46e-06	0.000257	CbGpPWpGaD
Mesalazine—CHUK—Disease—GCKR—Crohn's disease	6.44e-06	0.000256	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NOD1—Crohn's disease	6.43e-06	0.000256	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IL6—Crohn's disease	6.37e-06	0.000254	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	6.37e-06	0.000254	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—FADS1—Crohn's disease	6.35e-06	0.000253	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—NOD2—Crohn's disease	6.34e-06	0.000253	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—RASGRP1—Crohn's disease	6.34e-06	0.000252	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—SOCS1—Crohn's disease	6.33e-06	0.000252	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—JAK2—Crohn's disease	6.32e-06	0.000251	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD79A—Crohn's disease	6.32e-06	0.000251	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	6.29e-06	0.000251	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—Crohn's disease	6.29e-06	0.000251	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SEL1L—Crohn's disease	6.24e-06	0.000248	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—JAK2—Crohn's disease	6.21e-06	0.000247	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IFNG—Crohn's disease	6.2e-06	0.000247	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	6.1e-06	0.000243	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—Crohn's disease	6.07e-06	0.000242	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—TYK2—Crohn's disease	6e-06	0.000239	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	6e-06	0.000239	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—SOCS1—Crohn's disease	5.98e-06	0.000238	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RSPO3—Crohn's disease	5.96e-06	0.000237	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GPX4—Crohn's disease	5.95e-06	0.000237	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	5.93e-06	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—TYK2—Crohn's disease	5.9e-06	0.000235	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CCR6—Crohn's disease	5.84e-06	0.000233	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NOD1—Crohn's disease	5.83e-06	0.000232	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.8e-06	0.000231	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GCKR—Crohn's disease	5.74e-06	0.000229	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—SOCS1—Crohn's disease	5.74e-06	0.000229	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—JAK2—Crohn's disease	5.73e-06	0.000228	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MTMR3—Crohn's disease	5.71e-06	0.000227	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	5.71e-06	0.000227	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR9—Crohn's disease	5.7e-06	0.000227	CbGpPWpGaD
Mesalazine—CHUK—Disease—SLC11A1—Crohn's disease	5.69e-06	0.000227	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	5.67e-06	0.000226	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SEL1L—Crohn's disease	5.65e-06	0.000225	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—JAK2—Crohn's disease	5.63e-06	0.000224	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—Crohn's disease	5.62e-06	0.000224	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—Crohn's disease	5.61e-06	0.000223	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—Crohn's disease	5.61e-06	0.000223	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—HSPA1B—Crohn's disease	5.6e-06	0.000223	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RSPO3—Crohn's disease	5.56e-06	0.000222	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—Crohn's disease	5.53e-06	0.00022	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—Crohn's disease	5.48e-06	0.000218	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.45e-06	0.000217	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—Crohn's disease	5.36e-06	0.000214	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTPN2—Crohn's disease	5.34e-06	0.000213	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PLA2G4F—Crohn's disease	5.33e-06	0.000212	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GPR65—Crohn's disease	5.3e-06	0.000211	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CCR6—Crohn's disease	5.3e-06	0.000211	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RBX1—Crohn's disease	5.28e-06	0.00021	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—Crohn's disease	5.28e-06	0.00021	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SEL1L—Crohn's disease	5.27e-06	0.00021	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR9—Crohn's disease	5.17e-06	0.000206	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	5.14e-06	0.000205	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—Crohn's disease	5.08e-06	0.000202	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—Crohn's disease	5.04e-06	0.000201	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—Crohn's disease	5.02e-06	0.0002	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—Crohn's disease	5.01e-06	0.0002	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—Crohn's disease	4.99e-06	0.000199	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—Crohn's disease	4.97e-06	0.000198	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—Crohn's disease	4.97e-06	0.000198	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—UBE2D1—Crohn's disease	4.91e-06	0.000195	CbGpPWpGaD
Mesalazine—CHUK—Disease—RBX1—Crohn's disease	4.88e-06	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Disease—HSPA1B—Crohn's disease	4.88e-06	0.000194	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTPN2—Crohn's disease	4.85e-06	0.000193	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	4.84e-06	0.000193	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GPR65—Crohn's disease	4.81e-06	0.000191	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RBX1—Crohn's disease	4.79e-06	0.000191	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TLR4—Crohn's disease	4.77e-06	0.00019	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	4.75e-06	0.000189	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LTF—Crohn's disease	4.73e-06	0.000188	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—Crohn's disease	4.67e-06	0.000186	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—Crohn's disease	4.67e-06	0.000186	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	4.67e-06	0.000186	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—STAT3—Crohn's disease	4.64e-06	0.000185	CbGpPWpGaD
Mesalazine—CHUK—Immune System—UBE2D1—Crohn's disease	4.63e-06	0.000184	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—Crohn's disease	4.63e-06	0.000184	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—Crohn's disease	4.59e-06	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—Crohn's disease	4.57e-06	0.000182	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—STAT3—Crohn's disease	4.56e-06	0.000181	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MTMR3—Crohn's disease	4.53e-06	0.00018	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—Crohn's disease	4.51e-06	0.000179	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—Crohn's disease	4.5e-06	0.000179	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RIPK2—Crohn's disease	4.49e-06	0.000179	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ITGA4—Crohn's disease	4.49e-06	0.000179	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TYK2—Crohn's disease	4.48e-06	0.000178	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—FADS1—Crohn's disease	4.45e-06	0.000177	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—ICAM1—Crohn's disease	4.39e-06	0.000175	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL3—Crohn's disease	4.38e-06	0.000174	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR4—Crohn's disease	4.32e-06	0.000172	CbGpPWpGaD
Mesalazine—CHUK—Disease—UBE2D1—Crohn's disease	4.28e-06	0.00017	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—JAK2—Crohn's disease	4.27e-06	0.00017	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	4.24e-06	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RASGRP1—Crohn's disease	4.24e-06	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—Crohn's disease	4.22e-06	0.000168	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—Crohn's disease	4.2e-06	0.000167	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—UBE2D1—Crohn's disease	4.2e-06	0.000167	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GPX4—Crohn's disease	4.17e-06	0.000166	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TAB1—Crohn's disease	4.15e-06	0.000165	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	4.14e-06	0.000165	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—STAT3—Crohn's disease	4.13e-06	0.000165	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.1e-06	0.000163	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RIPK2—Crohn's disease	4.07e-06	0.000162	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ITGA4—Crohn's disease	4.07e-06	0.000162	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NOD2—Crohn's disease	4.07e-06	0.000162	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GCKR—Crohn's disease	4.02e-06	0.00016	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ICAM1—Crohn's disease	3.98e-06	0.000158	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL3—Crohn's disease	3.97e-06	0.000158	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RASGRP1—Crohn's disease	3.84e-06	0.000153	CbGpPWpGaD
Mesalazine—CHUK—Immune System—SOCS1—Crohn's disease	3.84e-06	0.000153	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—Crohn's disease	3.83e-06	0.000153	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	3.83e-06	0.000152	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GCKR—Crohn's disease	3.81e-06	0.000152	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR6—Crohn's disease	3.78e-06	0.00015	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TAB1—Crohn's disease	3.76e-06	0.00015	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TYK2—Crohn's disease	3.71e-06	0.000148	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NOD2—Crohn's disease	3.69e-06	0.000147	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.59e-06	0.000143	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—JAK2—Crohn's disease	3.54e-06	0.000141	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—FADS1—Crohn's disease	3.53e-06	0.000141	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SMAD3—Crohn's disease	3.51e-06	0.00014	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—SOCS1—Crohn's disease	3.48e-06	0.000139	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL18—Crohn's disease	3.46e-06	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR6—Crohn's disease	3.43e-06	0.000136	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RBX1—Crohn's disease	3.42e-06	0.000136	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SLC11A1—Crohn's disease	3.37e-06	0.000134	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TYK2—Crohn's disease	3.37e-06	0.000134	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—Crohn's disease	3.36e-06	0.000134	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTGER4—Crohn's disease	3.33e-06	0.000132	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GPX4—Crohn's disease	3.31e-06	0.000132	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—Crohn's disease	3.24e-06	0.000129	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.23e-06	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—Crohn's disease	3.22e-06	0.000128	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—JAK2—Crohn's disease	3.21e-06	0.000128	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCKR—Crohn's disease	3.19e-06	0.000127	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—Crohn's disease	3.18e-06	0.000127	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—STAT3—Crohn's disease	3.14e-06	0.000125	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL18—Crohn's disease	3.13e-06	0.000125	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RBX1—Crohn's disease	3.1e-06	0.000123	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2RA—Crohn's disease	3.07e-06	0.000122	CbGpPWpGaD
Mesalazine—CHUK—Disease—SMAD3—Crohn's disease	3.06e-06	0.000122	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—Crohn's disease	3.04e-06	0.000121	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTGER4—Crohn's disease	3.02e-06	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—UBE2D1—Crohn's disease	3e-06	0.000119	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—Crohn's disease	2.95e-06	0.000118	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—Crohn's disease	2.94e-06	0.000117	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—Crohn's disease	2.92e-06	0.000116	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RIPK2—Crohn's disease	2.9e-06	0.000116	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—Crohn's disease	2.9e-06	0.000115	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RBX1—Crohn's disease	2.89e-06	0.000115	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HSPA1B—Crohn's disease	2.89e-06	0.000115	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—Crohn's disease	2.89e-06	0.000115	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.87e-06	0.000114	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL3—Crohn's disease	2.83e-06	0.000113	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2RA—Crohn's disease	2.78e-06	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR4—Crohn's disease	2.78e-06	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RASGRP1—Crohn's disease	2.74e-06	0.000109	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—UBE2D1—Crohn's disease	2.72e-06	0.000108	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—Crohn's disease	2.71e-06	0.000108	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ICAM1—Crohn's disease	2.66e-06	0.000106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RIPK2—Crohn's disease	2.63e-06	0.000105	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—Crohn's disease	2.63e-06	0.000105	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—Crohn's disease	2.58e-06	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL3—Crohn's disease	2.57e-06	0.000102	CbGpPWpGaD
Mesalazine—PTGS2—Disease—UBE2D1—Crohn's disease	2.53e-06	0.000101	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR4—Crohn's disease	2.52e-06	0.0001	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.52e-06	0.0001	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RASGRP1—Crohn's disease	2.48e-06	9.89e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SOCS1—Crohn's disease	2.48e-06	9.88e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ICAM1—Crohn's disease	2.41e-06	9.61e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.28e-06	9.09e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SOCS1—Crohn's disease	2.25e-06	8.96e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—Crohn's disease	2.19e-06	8.72e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TYK2—Crohn's disease	2.16e-06	8.61e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SMAD3—Crohn's disease	2.14e-06	8.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—JAK2—Crohn's disease	2.06e-06	8.21e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—Crohn's disease	2.02e-06	8.06e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TYK2—Crohn's disease	2e-06	7.95e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2RA—Crohn's disease	1.98e-06	7.9e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TYK2—Crohn's disease	1.96e-06	7.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—Crohn's disease	1.96e-06	7.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SMAD3—Crohn's disease	1.94e-06	7.74e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—JAK2—Crohn's disease	1.9e-06	7.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—JAK2—Crohn's disease	1.87e-06	7.45e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—Crohn's disease	1.84e-06	7.31e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—Crohn's disease	1.83e-06	7.28e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—Crohn's disease	1.82e-06	7.23e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SMAD3—Crohn's disease	1.81e-06	7.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—Crohn's disease	1.81e-06	7.19e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—Crohn's disease	1.81e-06	7.19e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2RA—Crohn's disease	1.8e-06	7.16e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—Crohn's disease	1.79e-06	7.14e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—Crohn's disease	1.77e-06	7.06e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—Crohn's disease	1.65e-06	6.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—Crohn's disease	1.64e-06	6.52e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—Crohn's disease	1.6e-06	6.37e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—STAT3—Crohn's disease	1.51e-06	6.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TYK2—Crohn's disease	1.4e-06	5.57e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—STAT3—Crohn's disease	1.4e-06	5.57e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—STAT3—Crohn's disease	1.37e-06	5.47e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—JAK2—Crohn's disease	1.33e-06	5.31e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—Crohn's disease	1.28e-06	5.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TYK2—Crohn's disease	1.27e-06	5.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—Crohn's disease	1.22e-06	4.85e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—JAK2—Crohn's disease	1.21e-06	4.82e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TYK2—Crohn's disease	1.18e-06	4.71e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—JAK2—Crohn's disease	1.13e-06	4.49e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—Crohn's disease	1.12e-06	4.46e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—Crohn's disease	1.1e-06	4.4e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—Crohn's disease	1.07e-06	4.26e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—Crohn's disease	1.06e-06	4.21e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—Crohn's disease	1.02e-06	4.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—STAT3—Crohn's disease	9.79e-07	3.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—Crohn's disease	9.77e-07	3.89e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—Crohn's disease	9.59e-07	3.82e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STAT3—Crohn's disease	8.88e-07	3.53e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—STAT3—Crohn's disease	8.28e-07	3.3e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—Crohn's disease	6.84e-07	2.72e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—Crohn's disease	6.2e-07	2.47e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—Crohn's disease	5.78e-07	2.3e-05	CbGpPWpGaD
